Mydriatic effects using low concentrations of phenylephrine hydrochloride

Area of Science:

• Ophthalmology
• Pharmacology

Background:

• Phenylephrine is a common ophthalmic medication used to induce mydriasis (pupil dilation).
• Understanding the precise dose-response relationship is crucial for optimizing its clinical use and minimizing side effects.

Purpose of the Study:

• To determine the minimum effective concentration of phenylephrine for achieving maximum mydriasis.
• To evaluate the influence of a topical anesthetic on phenylephrine's dose-response relationship.

Main Methods:

• Investigated dose-response effects of various phenylephrine concentrations.
• Compared results with and without prior topical anesthetic application.
• Measured pupil size to quantify mydriasis.

Main Results:

• Mydriasis was observed with phenylephrine concentrations as low as 0.125%.
• Maximum mydriasis was consistently achieved at 2% phenylephrine.
• Concentrations above 2% yielded minimal additional dilation.
• A 1% phenylephrine concentration, combined with a topical anesthetic, proved therapeutically effective.

Conclusions:

• The optimal phenylephrine concentration for maximum mydriasis is 2%.
• A lower concentration of 1% phenylephrine may be therapeutically effective when combined with a topical anesthetic.
• Topical anesthetics can enhance the efficacy of phenylephrine, potentially allowing for lower doses.